DOI QR코드

DOI QR Code

An Experimental Study on Apoptosis of cultivated Wild Ginseng Distilled Herbal Acupuncture by Concentration Level

농도별(濃度別) 산양산삼(山養山蔘) 증류약침(蒸溜藥鐵)의 Apoptosis에 관(關)한 실험적(實驗的) 연구(硏究)

  • Cho, Hee-Chul (Department of Acupuncture and Moxibustion, Oriental Medicine, Sangji University) ;
  • Lee, Sun-Gu (Department of Pathology, Oriental Medicine, Sangji University) ;
  • Kwon, Ki-Rok (Department of Acupuncture and Moxibustion, Oriental Medicine, Sangji University)
  • 조희철 (상지대학교 한의과대학 침구학교실) ;
  • 이선구 (상지대학교 한의과대학 병리학교실) ;
  • 권기록 (상지대학교 한의과대학 침구학교실)
  • Published : 2004.06.25

Abstract

Objective : In order to measure the efficacy of cultivated wild ginseng distilled herbal acupuncture by concentration level, we've treated A549 human lung cancer lines with different concentrations of cultivated wild ginseng distilled herbal acupuncture and examined mRNA and proteins which take parts in apoptosis. Methods : A549 human lung cancer lines were treated with various concentration levels of cultivated wild ginseng distilled herbal acupuncture and cell toxicity was carefully examined. From the analysis of DNA fragmentation, RT-PCR and Western blot, manifestation of mRNA and proteins which are associated with apoptosis were inspected. Results : The following results were obtained on apoptosis of A549 human lung cancer lines after administering various concentration levels of cultivated wild ginseng distilled herbal acupuncture. 1. Measuring cell toxicity of lung cancer cells, strong cell toxicity was detected at high concentration level(1000ul, 1200ul), but no consistent concentration dependent reliance was detected. 2. Through DNA fragmentation, we were able to confirm cell destruction in all groups. 3. Experiment groups treated with cultivated wild ginseng distilled herbal acupuncture showed inhibition of Bcl-2 and COX-2 at mRNA and Protein level, whileas increase of Bax was shown. 4. Manifestation of p21, p53, Cyclin E, and Cyclin Dl were confirmed in all groups. 5. Extrication of Cytochrome C was detected at all groups, as well as increased activity of the enzyme caspase-3 and caspase-9, and PARP fragmentation were confirmed. Conclusion : According to the results, we can carefully deduce cell destruction of A549 human lung cancer lines were induced by Apoptosis. At the fixed level, cultivated wild ginseng distilled herbal acupuncture showed decrease of Bcl-2 and COX-2, as well as increase of Bax. Since cultivated wild ginseng distilled herbal acupuncture increases manifestation of p21, p53, Cyclin E, and Cyclin Dl, it affects cellular cycle and through these phenomena, we can consider extrication of Cytochrome C, increase of caspase, and PARP fragmentation are the results.

Keywords

References

  1. 신순식 외, 산삼 감정 기준의 객관성. 한의학연구소 동의 한의연 제 5집, pp.107-114. 2001. 12.
  2. 전국한의과대학 본초학교수공편저. 본초학. 서울, 영림사, p. 531, 1994.
  3. 중약대사전편찬위원회. 완역중약대사전 권7. 서울, 정담, pp. 3473-3479, 1997.
  4. 朝鮮總督府專賣局. 人蔘史. 서울, 法人文化社, pp. 3-4,5,1990.
  5. 張仲景. 仲景全書, 대성문화사, pp. 130,150,153,155,166,167,176,199,201,205,208,209,214,217,1984.
  6. 권기록 외, 山蔘에 대한 文獻的 考察. 대한약침학회지 Vol.6, No.2, p. 75, 2003. https://doi.org/10.3831/KPI.2003.6.2.067
  7. 이상인 외, 한약임상응용. 성보사, pp. 345-350, 1982.
  8. 하대유. 인삼에 대한 세포학 및 면역학적 연구. 대한 면역학회지 , Vol.1,No.1,pp.45-52, 1979.
  9. 山田昌之. 朝鮮人蔘의 硏究. 日本藥理學會誌 51 :390,1955.
  10. Brekhman I.I, Panax ginseng. Gosudarst Isdat et Med, Lit. Leningard, p.1 1957.
  11. Garriques. S, Panax Quinquefolia, Am Chem Pharm, 90: 331, 1954.
  12. 최진호., 인삼의 신비. 서울, 교문사, pp.13-14, 1984.
  13. Takagi, K, Proceedings International Ginseng Symposium, The Central Research Institute, Office of Monopoly, Seoul, Korea, p. 119, 1974.
  14. 권기록 외, 정맥주입용 산양산삼 증류약침의 급성.아급성 독성 실험 및 Sarcoma-180 항암 효과에 관한 실험적 연구, 대한약침학회지, Vol. 6, No.2, pp.7-27,2003. https://doi.org/10.3831/KPI.2003.6.2.007
  15. 권기록. 정맥주입용 산삼약침이 인체에 미치는 영향에 관한 임상적 연구. 대한약침학회지, Vol. 7,No. 1, pp. 15-26, 2004.
  16. 대한약침학회, 약침요법 시술 지침서, 대한약침학회, 서울,pp.13-14,112-118,138-203,1999.
  17. 강성길 외, 인삼수침이 진통 및 혈압에 미치는 영향, 동양의학학회지, Vol.11, No. 2,pp. 66-75, 1985.
  18. 김태윤 외, 인삼수침전처리가 발암예방에 미치는 영향, 대한한의학회지, Vol. 9, No. 2,pp. 33-44, 1988.
  19. 황경애 외, 인삼 및 녹용수침의 시간경과에 따른 면역효과연구, 경희의학, Vol. 4, No.2, pp. 150-157, 1988.
  20. 이혜정 외, 강혈당작용에 의거한 종류별 인삼수침 엑기스 제법연구, 대한한의학회지, Vol. 13, No.1, pp. 23-40, 1992.
  21. 김용석 외, 인삼수침이 흰쥐의 갑상선 기능저하에 미치는 영향, 경희의학, Vol. 6, No.2, pp. 202-210, 1990.
  22. 임하변 외, 인삼수침이 항 알레르기에 미치는 영향, 경희의학, Vol. 7, No.1, pp. 63-72, 1991.
  23. 김창일 외, 농도별 인삼수침이 hydrocortisone acetate를 투여한 흰쥐의 체내대사에 미치는 영향, 대한한의학회지, Vol. 9, No.2, pp. 33-44, 1988.
  24. 김웅시 외, 수삼, 백삼 및 홍삼수침이 Alloxan 당뇨병 흰쥐에 미치는 영향, 대한 침구학회지, Vol. 6, No.1,pp. 1-5,1989.
  25. Walker NI, Harmon BV, Gobe GC, Kerr JFR. Patterns of cell death. Methods Archive Exp Pathol 13 : 18-54, 1988.
  26. Ellis RE, Yuan J. Horvitz HR. Mechanisms and functions of cell death. Annu Rev Cell Biol 7 : 663-98, 1991. https://doi.org/10.1146/annurev.cb.07.110191.003311
  27. Jattela M. Escaping cell death, survival proteins in cancer. Exp Res 248: 30-43, 1999. https://doi.org/10.1006/excr.1999.4455
  28. Cohen GM. Caspases : the executioners of apoptosis. Biochem J 326: 1-16,1997.
  29. Hong SJ, Dawson TM, Dawson VL. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci. 25 : 259-64. 2004. https://doi.org/10.1016/j.tips.2004.03.005
  30. Sawaoka, H., Tsuji, S., Tsuji, M., Gunawan, E.S., Sasaki, Y., Kawano, S., Hori, M. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab. Invest. 79. pp. 1469-1477, 1999.
  31. Roose, T., Olivier, R., Monney, L., Rager, M., Conus, S., Fellay, I., Jansen, B., Borner, C. : Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature. 391,pp. 496-499,1998. https://doi.org/10.1038/35160
  32. Chiarugi, V., Magnelli, L., Cinelli., Basi, G. : Apoptosis and the cell cycle. Cell. Mol. Biol. Res. 40, pp. 603-612,1994.
  33. EI-Deiry, W.S., Harper, J.W., O'Connor, P.M., Velculescu, V.E., Canman, C.E., Jackman, J., Pietenpol, J.A., Burrell, M., Hill, D.E., Wang, Y., Wiman, K.G., Mercer, W.E., Kastan, M.B., Kohn, K.W., Elledge, S.J., Kinzler, K.W., Vogelstain, B. : WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res., 54,pp.1169-1174,1994.
  34. Miyashita, T., Reed, J.C. : Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, pp. 293-299,1995. https://doi.org/10.1016/0092-8674(95)90412-3
  35. Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J.W., Elledge, S., Nishimoto, T., Morgan, D.O., Franza, B.R., Roberts, J.M. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257, pp. 1689-1694,1992. https://doi.org/10.1126/science.1388288
  36. Ohtsubo, M., Roberts, J.M. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259, pp. 1908-1912. 1993. https://doi.org/10.1126/science.8384376
  37. Gu, Y., Turck, CW., Morgan, D.O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory submit. Nature 366. pp. 707-710,1993. https://doi.org/10.1038/366707a0
  38. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K, Elledge, S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75. pp.805-816, 1993. https://doi.org/10.1016/0092-8674(93)90499-G
  39. EI-Deiry, W.S., Harper, J.W., O'Connor, P.M., Velculescu, V.E., Canman, C.E., Jackman, L, Pietenpol, J.A., Burrell, M., Hill, D.E., Wang, Y., Wiman, K.G., Mercer, W.E., Kastan, M.B., Kohn, K.W., Elledge, S.J., Kinzler, K.W., Vogelstain, B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54. pp.1169-1174, 1994.
  40. El-Deiry, W.S., Harper, J.W., O'Connor, P.M., Velculescu, V.E., Canman, C.E., Jackman, J., Pietenpol, J.A, Burrell, M., Hill, D.E., Wang, Y., Wiman, K.G., Mercer, W.E., Kastan, M.B., Kohn, K.W., Elledge, S.J., Kinzler, K.W., Vogelstain, B. WAF!/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54 : 1169-1174.1994.
  41. Datto, M.B., Yu, Y., Wang, X.F. Functional analysis of the transforming growth factor $\beta$ responsive elements in the WAF/Cip1/p21 promoter. J. BioI. Chem. 270 : 28623-28628,1995. https://doi.org/10.1074/jbc.270.48.28623
  42. Zeng, Y.X., El-Deiry, W.S. Regulation of p21 WAF1/ CIP1 expression by p53-independent pathways. Oncogene 12 : 1557-1564,1996.
  43. Choi, Y.H., Lee, W.H., Park, K.Y., Zhang, L. p53 independent induction of p21(WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells. Jpn. J. Cancer Res. 91 : 164-173,2000. https://doi.org/10.1111/j.1349-7006.2000.tb00928.x
  44. Evans, V.G. : Multiple pathways to apoptosis. Cell Biol. Int.17, pp.461-476,1993. https://doi.org/10.1006/cbir.1993.1087
  45. Chiarugi, V., Magnelli, L., Cinelli., Basi, G. : Apoptosis and the cell cycle. Cell. Mol. BioI. Res. 40, pp. 603-612,1994.
  46. Kluck, R.M., Bessy-Wetzel, E., Green, D.R., Newmeyer, D.D. : The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, pp. 1132-1136, 1997. https://doi.org/10.1126/science.275.5303.1132
  47. Swanton C. Cell-cycle targeted therapies. Lancet Oncol. 5: 27-36, 2004. https://doi.org/10.1016/S1470-2045(03)01321-4

Cited by

  1. vol.9, pp.3, 2006, https://doi.org/10.3831/KPI.2006.9.3.011
  2. vol.9, pp.3, 2006, https://doi.org/10.3831/KPI.2006.9.3.079
  3. The Effects of distilled Wild Ginseng Herbal Acupuncture on the Heart Rate Variability(HRV) vol.11, pp.1, 2008, https://doi.org/10.3831/KPI.2008.11.1.055
  4. Analysis of Serum proteom before and after Intravenous Injection of wild ginseng herbal acupuncture vol.7, pp.3, 2004, https://doi.org/10.3831/KPI.2004.7.3.005
  5. Effects of distilled Cultivated Wild Ginseng Herbal Acupuncture in Rats with Diabetes Induced by High Fat Diet vol.8, pp.2, 2005, https://doi.org/10.3831/KPI.2005.8.2.097
  6. Intravenous Single-dose Toxicity of Mountain Ginseng Pharmacopuncture in Sprague-Dawley Rats vol.17, pp.3, 2014, https://doi.org/10.3831/KPI.2014.17.026
  7. vol.9, pp.3, 2006, https://doi.org/10.3831/KPI.2006.9.3.117
  8. Literary Study of Hyeolmaek(血脈) vol.8, pp.3, 2005, https://doi.org/10.3831/KPI.2005.8.3.011